From clinical trial to clinical practice: Evidence from the real world

The evolving treatment landscape for HER2-positive metastatic breast cancer

Navigating current treatment options for HER2-positive MBC: Patient journey 1

Thrombosis in adult patients with chronic ITP

Global prostate cancer disparities and the parts both genetic and behavioural factors play

Treatment options in adult chronic idiopathic thrombocytopenic purpura: Panel discussion

Melanoma live: Making patient-focused therapy decisions

Repurposing generics to fight cancer and the work of the ReDO Project

Looking for biomarkers in metronomic chemotherapy

Cost-effectiveness of metronomic approach to neuroblastoma and its use in combination with other therapies

New metronomic approach to neuroblastoma

Advances in multiple myeloma: Expert panel discussion